Cypherpunk Technologies (NASDAQ:CYPH) Share Price Passes Below 50 Day Moving Average – Time to Sell?

Posted by Francis Steltz on Aug 12th, 2026

Cypherpunk Technologies (NASDAQ:CYPH – Get Free Report)’s stock price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.69 and traded as low as $0.6635. Cypherpunk Technologies shares last traded at $0.68, with a volume of 801,697 shares trading hands.

Wall Street Analysts Forecast Growth

Several analysts have commented on CYPH shares. Weiss Ratings downgraded shares of Cypherpunk Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, July 31st. Cantor Fitzgerald upgraded shares of Cypherpunk Technologies to a “strong-buy” rating in a report on Friday, July 3rd. Finally, Wall Street Zen raised shares of Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $0.90.

Read Our Latest Research Report on CYPH

Cypherpunk Technologies Trading Up 0.0%

The stock has a market cap of $72.39 million, a price-to-earnings ratio of -33.98 and a beta of 0.09. The company has a 50 day simple moving average of $0.69 and a 200-day simple moving average of $0.78.

Cypherpunk Technologies (NASDAQ:CYPH – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.42).

Hedge Funds Weigh In On Cypherpunk Technologies

Hedge funds have recently made changes to their positions in the business. Acadian Asset Management LLC lifted its position in shares of Cypherpunk Technologies by 470.4% in the first quarter. Acadian Asset Management LLC now owns 1,280,531 shares of the company’s stock worth $389,000 after purchasing an additional 1,056,047 shares in the last quarter. Key Client Fiduciary Advisors LLC acquired a new position in Cypherpunk Technologies during the fourth quarter worth $98,000. Sequoia Financial Advisors LLC bought a new position in Cypherpunk Technologies in the fourth quarter valued at $56,000. HighTower Advisors LLC bought a new position in Cypherpunk Technologies in the fourth quarter valued at $59,000. Finally, Simplify Asset Management Inc. acquired a new stake in Cypherpunk Technologies in the 4th quarter valued at $2,172,000. 30.46% of the stock is owned by institutional investors.

About Cypherpunk Technologies

(Get Free Report)

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.